CAPROCK Group, Inc.
- SEC CIK
- 0001610769
- Latest filing
- Jul 27, 2026
ELTX holding history
Elicio Therapeutics, Inc. in every 13F filed by CAPROCK Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELTX overviewAll 13F holders of ELTXFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −1,573−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q1 2023 | 15,726 | $9.12K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 15,726 | $12.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 15,726 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 15,726 | $18.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 15,726 | $33.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 15,726 | $46.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 15,726 | $154.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 15,726 | $205.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 15,726 | $284.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.